GLENMARK2018-01-012018-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member GLENMARK2018-01-012018-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares GLENMARK 2017-04-01 2018-03-31 2018-05-16 INR Millions Yearly Single segment Pharmaceuticals 2018-01-01 2018-03-31 Audited Consolidated 22798160000.00 695520000.00 23493680000.00 6149420000.00 1734000000.00 -40390000.00 4642730000.00 743880000.00 735320000.00 7044050000.00 21009010000.00 2484670000.00 0.00 2484670000.00 961430000.00 6970000.00 968400000.00 0.00 1516270000.00 0.00 0.00 0.00 0.00 1516270000.00 -510500000.00 1005770000.00 0.00 0.00 1005300000.00 470000.00 282170000.00 1 0 5.37 5.37 0.00 0.00 5.37 5.37 2017-04-01 2018-03-31 Audited Consolidated 91030700000.00 914000000.00 91944700000.00 21501100000.00 7547450000.00 1337120000.00 18718410000.00 2855670000.00 3018760000.00 25772890000.00 80751400000.00 11193300000.00 0.00 11193300000.00 3256900000.00 -102300000.00 3154600000.00 0.00 8038700000.00 0.00 0.00 0.00 0.00 8038700000.00 -740070000.00 7298630000.00 0.00 0.00 7297710000.00 920000.00 282170000.00 1 0 0.00 28.49 28.49 0.00 0.00 28.49 28.49